reviewNatureJan 1, 2011Closed access

The challenge of new drug discovery for tuberculosis

AKAnil KoulÉAÉric ArnoultNLNacer LounisJGJérôme GuillemontKAKoen Andries

Janssen (Belgium) · Johnson & Johnson (United States) · +1 more institution

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

1,039
total citations
FWCI
60.74
Percentile
100%
References
70
Citations per year

Authors

5

Topics & keywords

Topics
Keywords
  • Tuberculosis
  • Drug discovery
  • Mycobacterium tuberculosis
  • Medicine
  • Variety (cybernetics)
  • Drug
  • Vaccination
  • Intensive care medicine
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.